{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T16:14:22Z","timestamp":1785687262504,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1999,5,7]],"date-time":"1999-05-07T00:00:00Z","timestamp":926035200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,6]]},"DOI":"10.1038\/sj.bjc.6690462","type":"journal-article","created":{"date-parts":[[2002,9,5]],"date-time":"2002-09-05T18:05:47Z","timestamp":1031249147000},"page":"1052-1057","source":"Crossref","is-referenced-by-count":26,"title":["Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer"],"prefix":"10.1038","volume":"80","author":[{"given":"A van der","family":"Gaast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T C","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Kerkhofs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P D","family":"Siersema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H W","family":"Tilanus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T A W","family":"Splinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[1999,5,7]]},"reference":[{"key":"BF6690462_CR1","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/jnci\/86.14.1086","volume":"86","author":"JA Ajani","year":"1994","unstructured":"Ajani, J. A., Ilson, D. H., Daugherty, K., Pazdur, R., Lynch, P. M. & Kelsen, D. P. (1994). Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 86: 1086\u20131091.","journal-title":"J Natl Cancer Inst"},{"key":"BF6690462_CR2","first-page":"55","volume":"23","author":"JA Ajani","year":"1996","unstructured":"Ajani, J. A., Ilson, D. H. & Kelsen, D. P. (1996). Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas. Semin Oncol 23: 55\u201358.","journal-title":"Semin Oncol"},{"key":"BF6690462_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1006\/gyno.1996.0210","volume":"62","author":"E Connelly","year":"1996","unstructured":"Connelly, E., Markman, M., Kennedy, A., Webster, K., Kulp, B., Peterson, G. & Belinson, J. (1996). Paclitaxel delivered as 3-hr infusion with cisplatin in patients with gynecologic cancers: unexpected incidence of neurotoxicity. Gynecol Oncol 62: 166\u2013168.","journal-title":"Gynecol Oncol"},{"key":"BF6690462_CR4","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1820::AID-CNCR25>3.0.CO;2-Z","volume":"78","author":"JM Daly","year":"1996","unstructured":"Daly, J. M., Karnell, L. & Menck, H. R. (1996). National Cancer Data Base report on esophageal carcinoma. Cancer 78: 1820\u20131828.","journal-title":"Cancer"},{"key":"BF6690462_CR5","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.1994.12.12.2654","volume":"12","author":"EA Eisenhauer","year":"1994","unstructured":"Eisenhauer, E. A., ten Bokkel Huinink, W. W., Swenerton, K. D., Gianni, L., Myles, J., van der Burg, M. E. L., Kerr, I., Vermorken, J. B., Buser, K., Colombo, N., Bacon, M., Santabarbara, P., Onetto, N., Winograd, W. & Canetta, R. (1994). European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. J Clin Oncol 12: 2654\u20132666.","journal-title":"J Clin Oncol"},{"key":"BF6690462_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1200\/JCO.1997.15.1.187","volume":"15","author":"D Fennelly","year":"1997","unstructured":"Fennelly, D., Aghajanian, C., Shapiro, F., O\u2019Flaherty, C., McKenzie, M., O\u2019Connor, C., Tong, W., Norton, L. & Spriggs, D. (1997). Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer. J Clin Oncol 15: 187\u2013192.","journal-title":"J Clin Oncol"},{"key":"BF6690462_CR7","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1200\/JCO.1996.14.4.1185","volume":"14","author":"KA Gelmon","year":"1996","unstructured":"Gelmon, K. A., O\u2019Reilly, S. E., Tolcher, A. W., Campbell, C., Bryce, C., Ragaz, J., Coppin, C., Plenderleith, I. H., Ayers, D., McDermott, B., Nakashima, L., Healy, D. & Onetto, N. (1996a). Phase I\/II trial of bi-weekly paclitaxel and cisplatin in the treatment of metastatic breast cancer. J Clin Oncol 14: 1185\u20131191.","journal-title":"J Clin Oncol"},{"key":"BF6690462_CR8","unstructured":"Gelmon, K. A., Murray, N., Melosky, B., Shah, A., Page, R., Dulude, H. & Rielly, S. (1996b). Phase I\/II study of biweekly paclitaxel and cisplatin in non-small-cell lung cancer. Proc Am Soc Clin Oncol 15: 405 (Abstract)"},{"key":"BF6690462_CR9","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1200\/JCO.1997.15.5.1965","volume":"15","author":"AN Gordon","year":"1997","unstructured":"Gordon, A. N., Stringer, C. A., Matthews, C. M., Willis, D. L. & Nemunaitis, J. (1997). Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting. J Clin Oncol 15: 1965\u20131973.","journal-title":"J Clin Oncol"},{"key":"BF6690462_CR10","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","volume":"326","author":"A Herskovic","year":"1992","unstructured":"Herskovic, A., Martz, K., al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L. & Emami, B. (1992). Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326: 1593\u20131598.","journal-title":"N Engl J Med"},{"key":"BF6690462_CR11","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/0959-8049(94)00497-S","volume":"31","author":"PH Hilkens","year":"1995","unstructured":"Hilkens, P. H., van der Burg, M. E., Moll, J. W., Planting, A. S., van Putten, W. L., Vecht, C. J. & van den Bent, M. J. (1995). Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration. Eur J Cancer 31: 678\u2013681.","journal-title":"Eur J Cancer"},{"key":"BF6690462_CR12","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/jnci\/82.15.1247","volume":"82","author":"FA Holmes","year":"1990","unstructured":"Holmes, F. A., Walters, R. S., Theriault, R. L., Forman, A. D., Newton, L. K., Raber, M. N., Buzdar, A. U., Frye, D. K. & Hortobagyi, G. N. (1990). Phase II trial of Taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 82: 1247\u20131249.","journal-title":"J Natl Cancer Inst"},{"key":"BF6690462_CR13","unstructured":"Kelsen, D., Ginsberg, R., Qian, C., Gunderson, L., Mortimer, J., Estes, N., Hailer, D., Ajani, J., Kocha, W., Roth, J. & Minsky, B. (1997). Chemotherapy followed by operation versus operation alone in the treatment of patients with localized esophageal cancer: a preliminary report of intergroup study 113 (RTOG 89-11). Proc Am Soc Clin Oncol 16: 276 (Abstract)"},{"key":"BF6690462_CR14","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/bjc.1996.469","volume":"74","author":"TC Kok","year":"1996","unstructured":"Kok, T. C., van der Gaast, A., Stoter, G., Tilanus, H., Eykenboom, W., Dees, J., van Overhagen, H. & Splinter, T. (1996). Cisplatin and etoposide in esophageal cancer. A phase II study. Br J Cancer 74: 980\u2013984.","journal-title":"Br J Cancer"},{"key":"BF6690462_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0305-7372(97)90021-9","volume":"23","author":"TC Kok","year":"1997","unstructured":"Kok, T. C. (1997). Chemotherapy in esophageal cancer: a review. Cancer Treat Rev 23: 65\u201385.","journal-title":"Cancer Treat Rev"},{"key":"BF6690462_CR16","unstructured":"Kok, T. C., van Lanschot, J., Siersema, P. D., van Overhagen, H. & Tilanus, H. W. (1997). Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial. Proc Am Soc Clin Oncol 16: 277 (Abstract)"},{"key":"BF6690462_CR17","unstructured":"McCaskill-Stevens, W., Ansari, R., Fisher, W., Pennington, K., Dobbs, C., Gonin, R., Schaefer, S., Loesch, D. & Sledge, G. (1996). Phase II study of biweekly cisplatin and paclitaxel in the treatment of metastatic breast cancer. Proc Am Soc Clin Oncol 15: 120 (Abstract)"},{"key":"BF6690462_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199601043340101","volume":"334","author":"WP McGuire","year":"1996","unstructured":"McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L. & Davidson, M. (1996). Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and IV ovarian cancer. N Engl J Med 334: 1\u20136.","journal-title":"N Engl J Med"},{"key":"BF6690462_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/oxfordjournals.annonc.a059237","volume":"6","author":"S O\u2019Reilly","year":"1995","unstructured":"O\u2019Reilly, S. & Forastiere, A. (1995). Is surgery necessary with multimodality treatment of esophageal cancer? Ann Oncol 6: 519\u2013521.","journal-title":"Ann Oncol"},{"key":"BF6690462_CR20","unstructured":"Parimoo, D., Garcia, A., Muggia, F., Dimery, I., Rogers, M. & Jeffers, S. (1996). Tolerance of paclitaxel (Taxol) 3-hr infusion with G-CSF on a biweekly schedule. Proc Am Soc Clin Oncol 15: 181 (Abstract)"},{"key":"BF6690462_CR21","first-page":"453","volume":"21","author":"JA Roth","year":"1994","unstructured":"Roth, J. A. & Putnam, J. B. Jr (1994). Surgery for cancer of the esophagus. Sem Oncol 21: 453\u2013461.","journal-title":"Sem Oncol"},{"key":"BF6690462_CR22","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1200\/JCO.1993.11.10.2010","volume":"11","author":"EK Rowinsky","year":"1993","unstructured":"Rowinsky, E. K., Chaudhry, V., Forastiere, A., Sartorius, S. E., Ettinger, D. S., Grochow, L. B., Lubejko, B. G., Cornblath, D. R. & Donehower, R. C. (1993). Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting. J Clin Oncol 11: 2010\u20132020.","journal-title":"J Clin Oncol"},{"key":"BF6690462_CR23","first-page":"S12.18","volume":"24","author":"JB S\u00f8renson","year":"1997","unstructured":"S\u00f8renson, J. B., Wedervang, K. & Dombernowsky, P. (1997). Preliminary results of a phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer. Semin Oncol 24: S12.18\u2013S12.20.","journal-title":"Semin Oncol"},{"key":"BF6690462_CR24","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1200\/JCO.1997.15.5.1880","volume":"15","author":"JA Sparano","year":"1997","unstructured":"Sparano, J. A., Neuberg, D., Glick, J. H., Robert, N. J., Goldstein, L. J., Sledge, G. W. & Wood, W. (1997). Phase II trial of bi-weekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group study. J Clin Oncol 15: 1880\u20131004.","journal-title":"J Clin Oncol"},{"key":"BF6690462_CR25","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/oxfordjournals.annonc.a010502","volume":"7","author":"K Swenerton","year":"1996","unstructured":"Swenerton, K., Hoskins, P., Stuart, G., Batist, G., Pike, J., Onetto, N., Fisher, B. & Eisenhauer, E. (1996). A phase I study of biweekly paclitaxel\/cisplatin as initial therapy for advanced ovarian cancer. A study of the National Cancer Institute of Canada Clinical Trials Group. Ann Oncol 7: 1077\u20131079.","journal-title":"Ann Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690462.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690462","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690462.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:53:41Z","timestamp":1684414421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1999,6]]}},"alternative-id":["BF6690462"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690462","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5,7]]}}}